Community Healthcare Trust/$CHCT
1D1W1MYTD1Y5YMAX
Capital at risk
About Community Healthcare Trust
Community Healthcare Trust Inc is an integrated healthcare real estate company in the United States. The company owns and acquires, or finances, real estate properties that are leased to hospitals, doctors, healthcare systems, or other healthcare service providers in non-urban markets. The company derives the majority of its revenues from its real estate property and mortgage notes portfolio. The company's rental and mortgage interest income is recognized based on contractual arrangements with its tenants and borrowers.
- Ticker
- $CHCT
- Sector
- Real Estate
- Primary listing
- NYSE
- Employees
- 35
- Headquarters
- Franklin, United States
- Website
- www.chct.reit
CHCT Metrics
BasicAdvanced
$383M
21.32
$0.66
0.68
$1.76
9.32%
Price and volume
Market cap
$383M
Beta
0.68
52-week high
$19.17
52-week low
$13.23
Average daily volume
364K
Dividend rate
$1.76
Financial strength
Current ratio
3.026
Quick ratio
2.548
Long term debt to equity
1.36
Total debt to equity
1.36
Dividend payout ratio (TTM)
259.50%
Interest coverage (TTM)
1.18%
Profitability
EBITDA (TTM)
78.157
Gross margin (TTM)
80.62%
Net profit margin (TTM)
16.81%
Operating margin (TTM)
26.82%
Effective tax rate (TTM)
0.05%
Revenue per employee (TTM)
$3,570,000
Management effectiveness
Return on assets (TTM)
2.12%
Return on equity (TTM)
4.92%
Valuation
Price to earnings (TTM)
21.323
Price to revenue (TTM)
3.063
Price to book
0.93
Price to tangible book (TTM)
0.93
Price to free cash flow (TTM)
6.425
Free cash flow yield (TTM)
15.57%
Free cash flow per share (TTM)
2.206
Dividend yield (TTM)
12.44%
Forward dividend yield
9.32%
Growth
Revenue change (TTM)
5.66%
Earnings per share change (TTM)
-270.48%
3-year revenue growth (CAGR)
5.88%
10-year revenue growth (CAGR)
20.61%
3-year earnings per share growth (CAGR)
27.92%
10-year earnings per share growth (CAGR)
24.58%
3-year dividend per share growth (CAGR)
-0.61%
10-year dividend per share growth (CAGR)
1.52%
Bulls say / Bears say
CHCT has a contracted acquisition pipeline of about $99 million, with expected initial returns of 9.1% to 9.75% and roughly 2.5% rent escalators. Management also expects $85 million to $90 million of acquisitions in 2026, above the $72.1 million completed in 2025. (PR Newswire, The Motley Fool)
Leasing momentum offers a clear route to higher income. CHCT has signed more than 100,000 square feet of new leases year to date, targets 92% occupancy within 18 months and estimates that the occupancy and rent gains could add up to $6 million of NOI. (The Motley Fool, PR Newswire)
The new capital plan could fund growth without relying as heavily on new shares or debt. The dividend reset is expected to retain $25 million to $30 million over two years, while seven property sales have generated $38.5 million and more than $70 million of further assets are being marketed for recycling. (PR Newswire, The Motley Fool)
CHCT cut its quarterly dividend by 31%, from $0.48 to $0.33 per share. That improves retention, but it materially reduces the immediate income appeal and shows the previous payout left too little cash for investment. (PR Newswire, The Motley Fool)
Near-term growth has not yet appeared in the results: second-quarter AFFO was $0.56 per share, unchanged from the first quarter, while reported earnings and revenue missed published estimates. The occupancy and acquisition targets are therefore still execution promises rather than delivered growth. (PR Newswire, The Lincolnian Online)
The balance sheet remains exposed to floating-rate costs: $285 million was drawn on the revolver at about 5.3% in the first quarter, and hedges covering $75 million expired in March. Higher interest expense could absorb part of the benefit from new leasing and acquisitions. (Last10K, StockTitan)
Data summarised monthly by Lightyear AI. Last updated on 20 Sept 2026.
Upcoming events
No upcoming events
CHCT News
AllArticlesVideos
Funds containing CHCT
Fund name | Fund size | $CHCT weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
